All Stories

  1. A model to describe the drug concentration and pharmacological effect time-courses for etrolizumab
  2. Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
  3. Short‐Term Efficacy Reliably Predicts Long‐Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model‐Based Meta‐Analysis
  4. Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production